Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00738751 |
|
Recruitment Status :
Completed
First Posted : August 20, 2008
Last Update Posted : February 4, 2015
|
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborators:
Genentech, Inc.
Novartis
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | August 2013 |
| Actual Study Completion Date : | February 2015 |